Archives

  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • br Derks K et al Impact of brachytherapy technique D

    2022-05-06


    Derks K., et al., 2018. Impact of brachytherapy technique (2D versus 3D) on outcome following
    radiotherapy of cervical cancer. J Contemp Brachytherapy. 10:17–25.
    Dimopoulos JC., et al., 2009. Dose-volume histogram parameters and local tumor control in magnetic
    ACCEPTED MANUSCRIPT
    resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 75:56–63.
    Georg P., et al., 2011. Dose-volume histogram parameters and late side effects in magnetic resonance
    image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 79:356–62.
    Kang HC., et al., 2010. 3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact
    on late rectal bleeding and local control. Radiother Oncol. 97:507-13.
    Kato S., et al., 2010. CT-based 3D dose-volume parameter of the rectum and late rectal complication
    in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy. J Radiat Res.
    Nakano T., et al., 2007. Long-term results of high-dose rate intracavitary brachytherapy for squamous
    Noda SE., et al., 2007. Late rectal complications evaluated by computed tomography-based dose
    calculations in patients with cervical carcinoma undergoing high-dose-rate brachytherapy. Int J Radiat
    Ohno T., et al., 2015. A questionnaire-based survey on 3D image-guided brachytherapy for cervical
    Pötter R., et al., 2011. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy
    combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally
    Rose PG., et al.,2007. Long-term follow-up of Acarbose randomized trial comparing concurrent single agent
    ACCEPTED MANUSCRIPT
    cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for
    locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 25:2804-10.
    Shin KH., et al., 2006. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of
    conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume
    Sturdza A., et al., 2016. Image guided brachytherapy in locally advanced cervical cancer: Improved
    pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol.
    Toita T., et al.,2012. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary
    brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low
    cumulative radiation dose schedule. Gynecol Oncol. 126:211-6.
    Wong FC., et al., 2003. Treatment results of high-dose-rate remote afterloading brachytherapy for
    cervical cancer and retrospective comparison of two regimens. Int J Radiat Oncol Biol Phys. 55:1254–
    ACCEPTED MANUSCRIPT
    Table 1. Patient and tumor characteristics
    All 2D IGBT p
    group group
    n
    Pathology Sqcc
    ACCEPTED MANUSCRIPT
    FIGO stage ⅠB
    ACCEPTED MANUSCRIPT
    Complications DM
    Abbreviations: Sqcc, squamous cell carcinoma; Adeno, adenocarcinoma; Adsq, adenosquamous carcinoma; DM, diabetes mellitus
    ACCEPTED MANUSCRIPT
    Table 2. Predictive factors of rectal complication
    UVA MVA
    5-year p
    HR
    Factors
    incidence value
    IV
    Gy
    ACCEPTED MANUSCRIPT
    No
    Abbreviations: DM, diabetes mellitus; UVA,
    univariate analysis; MVA, multivariate analysis; HR,
    hazard ratio; CI, confidence interval
    ACCEPTED MANUSCRIPT
    Table 3. Dose comparison between the 2D group and the IGBT group
    2D group IGBT group
    Factors Mean (Range) Mean (Range) p
    ACCEPTED MANUSCRIPT
    Figure legends
    Fig. 1b The incidence of rectal complications tended to be lower in the IGBT group (5-year incidence rate in the
    ACCEPTED MANUSCRIPT
    Research Highlight
    · The difference of the treatment results between 2D and 3D brachytherapy was analyzed.
    · The rectum D2cc was significantly lower in the IGBT group compared with the 2D group.
    · Local control rates tended to be better in the IGBT group than in the 2D group.
    · The incidence of rectal complications tended to be lower in the IGBT group.
    Contents lists available at ScienceDirect
    Current Problems in Cancer
    journal homepage: www.elsevier.com/locate/cpcancer
    Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience